The Federal Trade Commission on Tuesday announced that it has launched an inquiry in the ongoing U.S. baby-formula shortage. “The inquiry seeks information about the nature and prevalence of any deceptive, fraudulent, or otherwise unfair business practices aimed at taking advantage of families during this shortage,” the agency said in a statement. “It also aims to shed light on the factors that have led to concentration in the infant formula market and the fragility of the supply chains for these crucial products.”

Read Next

Read Next

After 3 months of war, life in Russia has profoundly changed

When Vladimir Putin announced the invasion of Ukraine, war seemed far away from Russian territory. Yet within days the conflict came home — not with cruise missiles and mortars but in the form of unprecedented and unexpectedly extensive volleys of sanctions by Western governments and economic punishment by corporations.

About the Author

Victor Reklaitis is MarketWatch’s Money & Politics reporter and is based in Washington, D.C. Prior to joining MarketWatch, he served as an assistant editor and reporter at Investor’s Business Daily. Before IBD, he worked for several newspapers in Virginia. Follow Victor on Twitter at: @vicrek.